Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bert Vogelstein

Showing results (51-60 of 332) with videos related to

Pageof 34
Sort By:
Nature|August 11, 2017
Role of stem-cell divisions in cancer riskCristian Tomasetti, Rick Durrett, Marek Kimmel, et al.
Cancer Research|May 6, 2004
X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cellsJordan M Cummins, Manu Kohli, Carlo Rago, et al.
Science Translational Medicine|August 30, 2019
Applications of liquid biopsies for cancerAustin K Mattox, Chetan Bettegowda, Shibin Zhou, et al.
Cancer Discovery|August 20, 2025
Translating Artificial Intelligence Breakthroughs into Cancer Diagnostic BreakthroughsJuan M Lavista Ferres, Elliot K Fishman, Ed Catmull, et al.
Nature Reviews. Cancer|July 18, 2008
Structural comparisons of class I phosphoinositide 3-kinasesL Mario Amzel, Chuan-Hsiang Huang, Diana Mandelker, et al.
Science (New York, N.Y.)|March 30, 2013
Cancer genome landscapesBert Vogelstein, Nickolas Papadopoulos, Victor E Velculescu, et al.
Nature|August 27, 2015
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneityBartlomiej Waclaw, Ivana Bozic, Meredith E Pittman, et al.
Science Translational Medicine|April 5, 2012
The predictive capacity of personal genome sequencingNicholas J Roberts, Joshua T Vogelstein, Giovanni Parmigiani, et al.
Science (New York, N.Y.)|November 25, 2006
A bacterial protein enhances the release and efficacy of liposomal cancer drugsIan Cheong, Xin Huang, Chetan Bettegowda, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2002
DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activitiesLeigh Zawel, Jian Yu, Christopher J Torrance, et al.
Pageof 34

Showing results (51-60 of 332) with videos related to

Sort By:
Pageof 34
Nature|August 11, 2017
Role of stem-cell divisions in cancer riskCristian Tomasetti, Rick Durrett, Marek Kimmel, et al.
Cancer Research|May 6, 2004
X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cellsJordan M Cummins, Manu Kohli, Carlo Rago, et al.
Science Translational Medicine|August 30, 2019
Applications of liquid biopsies for cancerAustin K Mattox, Chetan Bettegowda, Shibin Zhou, et al.
Cancer Discovery|August 20, 2025
Translating Artificial Intelligence Breakthroughs into Cancer Diagnostic BreakthroughsJuan M Lavista Ferres, Elliot K Fishman, Ed Catmull, et al.
Nature Reviews. Cancer|July 18, 2008
Structural comparisons of class I phosphoinositide 3-kinasesL Mario Amzel, Chuan-Hsiang Huang, Diana Mandelker, et al.
Science (New York, N.Y.)|March 30, 2013
Cancer genome landscapesBert Vogelstein, Nickolas Papadopoulos, Victor E Velculescu, et al.
Nature|August 27, 2015
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneityBartlomiej Waclaw, Ivana Bozic, Meredith E Pittman, et al.
Science Translational Medicine|April 5, 2012
The predictive capacity of personal genome sequencingNicholas J Roberts, Joshua T Vogelstein, Giovanni Parmigiani, et al.
Science (New York, N.Y.)|November 25, 2006
A bacterial protein enhances the release and efficacy of liposomal cancer drugsIan Cheong, Xin Huang, Chetan Bettegowda, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2002
DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activitiesLeigh Zawel, Jian Yu, Christopher J Torrance, et al.
Pageof 34